Current Medicinal Chemistry
Title:Editorial (Thematic Issue: New Antimicrobial Therapeutics)
Volume: 22 Issue: 18
Author(s): André Luis Souza dos Santos, Marta Helena Branquinha, Claudia Masini d’Avila-Levy, Lucimar Ferreira Kneipp and Cátia Lacerda Sodré
Affiliation:
Export Options
About this article
Cite this article as:
Souza dos Santos André Luis, Helena Branquinha Marta, d’Avila-Levy Claudia Masini, Ferreira Kneipp Lucimar and Lacerda Sodré Cátia, Editorial (Thematic Issue: New Antimicrobial Therapeutics), Current Medicinal Chemistry 2015; 22 (18) . https://dx.doi.org/10.2174/0929867322666150608093816
DOI https://dx.doi.org/10.2174/0929867322666150608093816 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Application of High Throughput siRNA Screening Technology to Study Host-Pathogen Interactions
Combinatorial Chemistry & High Throughput Screening Armed Imidazo [1,2-a] Pyrimidines (Pyridines): Evaluation of Antibacterial Activity
Letters in Drug Design & Discovery The TB Structural Genomics Consortium: Providing a Structural Foundation for Drug Discovery
Current Drug Targets - Infectious Disorders New Developments in Antimicrobial Use in Sepsis
Current Pharmaceutical Design Resolving Differences in Substrate Specificities between Human and Parasite Phosphoribosyltransferases via Analysis of Functional Groups of Substrates and Receptors
Current Pharmaceutical Design The Risk of Progressive Multifocal Leukoencephalopathy Under Biological Agents Used in the Treatment of Chronic Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) MenA Is a Promising Drug Target for Developing Novel Lead Molecules to Combat Mycobacterium tuberculosis
Medicinal Chemistry Current Treatment and Drug Discovery Against Leishmania spp. and Plasmodium spp.: A Review
Current Drug Targets Effect of Sulfonamides on the Electrophysical Properties of Bacterial Cells
Anti-Infective Agents Pharmaceutical Care: Past, Present and Future
Current Pharmaceutical Design Advances in Antimicrobial Natural Products Derived from Marine Actinomycetes
Mini-Reviews in Organic Chemistry Playing with Fire: Manipulation of Macrophage Proinflammatory Signal Transduction by the Intracellular Protozoan Toxoplasma gondii
Current Immunology Reviews (Discontinued) Patent Selections:
Recent Patents on Anti-Infective Drug Discovery Fungal Zinc Homeostasis – A Tug of War Between the Pathogen and Host
Current Medicinal Chemistry Polymorphic Receptors of the Innate Immune System (MBL/MASP-2 and TLR2/4) and Susceptibility to Pneumococcal Bacteremia in HIV-Infected Patients: A Case-Control Study
Current HIV Research HIV-1 Infection In Children: A Clinical and Immunologic Overview
Current HIV Research New Plates for Different Types of Plate Heat Exchangers
Recent Patents on Mechanical Engineering One-Step Synthesis of 1H-1,2,3-Triazol-1-Ylmethyl-2,3-Dihydronaphtho[1,2-b]furan- 4,5-Diones
Current Organic Synthesis Silicosis in Current Scenario: A Review of Literature
Current Respiratory Medicine Reviews 3,4-DHQLO and Triazole and Its Related Analogues with Anticonvulsant Effects
Mini-Reviews in Medicinal Chemistry